The Diabetes Trials Unit (DTU) is a fully registered UK Clinical Research Collaboration Clinical Trials Unit, specialising in performing local, national and multinational clinical trials related to the treatment and management of cardiometabolic and related disorders.[More about the DTU]
Patients and the public can get involved in research in a number of ways, including as a participant in a trial, by determining research priorities, or by contributing to the design or dissemination of research. Read more about getting involved here
Watch our video to hear the experience of previous trial participants and the views of our research staff.
Participants in our trials may be patients, with diabetes or other medical conditions, or healthy volunteers. Please visit our Trials page if you are interested getting involved to see our trials that are recruiting currently.
The Diabetes Trials Unit is resuming the COPCOV trial in the UK following renewed approval from UK regulators. This important global trial will answer the question whether health-care workers who take hydroxychloroquine, compared with a placebo, will have lower risk of getting COVID-19....[Read more...]
With the Mahidol Oxford Tropical Medicine Research Unit (MORU), the Diabetes Trials Unit is running the COPCOV trial in the UK. This important global trial will answer the question whether health-care workers who take hydroxychloroquine, compared with a placebo, will have lower risk of getting COVID-19....[Read more...]
COPCOV begins to enrol patients at Brighton and Sussex University Hospitals NHS Trust and at Oxford University Hospitals NHS Foundation Trust.